knowledge -WSS

knowledge

author：fashion 2025-09-30 18:53:59 - browse：711

When is a failure not a failure? Does the FDA have special rules for Sarepta Therapeutics? And how do you say “brash” in French?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Biotech consultant Frank David joins us to explain the wild world of subgroup analyses and how to discern science from spin. We also discuss the latest news in the life sciences, including the future of Sarepta and the retirement of a biotech stalwart.

For more on what we cover, here’s where you can read Frank’s work; here’s more on Sarepta; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Peter Hotez and the public health issue of online harassment
Next article： The story of mRNA: From a loose idea to a tool that may help curb Covid

focus

WSS

The battle over 'scope creep' and who gets to be called 'doctor'

How doctors’ personal politics affect patients

Why we need to separate burnout from moral injury in health care

What would happen to your eyes if you looked at the solar eclipse?

'Investigate these claims': UFO transparency at center of House hearing

CDC concerned about possible undetected monkeypox spread in U.K.

entertainment

knowledge

hotspot

Affirmative action in medical school literally saved lives

Gene therapy has helped boys walk. Can scientists keep it that way?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The story of mRNA: From a loose idea to a tool that may help curb Covid

Peter Hotez and the public health issue of online harassment

Cloning humans is technically possible. It's curious no one has tried

Medical leaders decry Supreme Court decision on affirmative action

UHS says company favors patients whose insurance pays more

State Dept. review finds Biden bears some blame for Afghanistan failures

Disclosing genetic information: not as worrisome as once feared

hotspot

New lawsuit accuses health insurer Cigna of denying claims in bulk

New guidelines on severe brain injury complicate already difficult decisions

CDC concerned about possible undetected monkeypox spread in U.K.

Cloning humans is technically possible. It's curious no one has tried

CDC concerned about possible undetected monkeypox spread in U.K.

Rise in cancer among younger people worries and puzzles doctors

focus

knowledge

entertainment

focus